Compare CMCO & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMCO | ATRC |
|---|---|---|
| Founded | 1875 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 555.6M | 2.5B |
| IPO Year | 2002 | 2005 |
| Metric | CMCO | ATRC |
|---|---|---|
| Price | $16.52 | $58.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $21.00 | ★ $51.17 |
| AVG Volume (30 Days) | 352.9K | ★ 963.3K |
| Earning Date | 05-27-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.90% | N/A |
| EPS Growth | N/A | ★ 74.74 |
| EPS | N/A | ★ 0.18 |
| Revenue | ★ $936,240,000.00 | $201,630,000.00 |
| Revenue This Year | $19.73 | $15.27 |
| Revenue Next Year | $82.91 | $12.21 |
| P/E Ratio | ★ N/A | $324.00 |
| Revenue Growth | 3.27 | ★ 15.40 |
| 52 Week Low | $11.99 | $25.36 |
| 52 Week High | $24.40 | $59.88 |
| Indicator | CMCO | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 43.27 | 76.32 |
| Support Level | $13.45 | $26.95 |
| Resistance Level | $16.42 | N/A |
| Average True Range (ATR) | 0.74 | 2.08 |
| MACD | -0.22 | 0.10 |
| Stochastic Oscillator | 24.03 | 81.91 |
Columbus McKinnon Corp is a world-wide designer, manufacturer and marketer of intelligent motion solutions for material handling that move the world forward and improve lives by efficiently and ergonomically moving, lifting, positioning and securing materials. Its key products include hoists, crane components, precision conveyor systems, rigging tools, light rail workstations and digital power and motion control systems. These are relevant, professional-grade solutions that solve its customers critical material handling requirements. The company has one operating and reportable segment. It has presence in United State, Germany, Europe, Middle East, and Africa (Excluding Germany), Canada, Asia Pacific, and Latin America. It has majority of sales from United States.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.